MARKET

XTLB

XTLB

X T L Bio
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.383
+0.033
+2.41%
Closed 16:00 10/22 EDT
OPEN
1.400
PREV CLOSE
1.350
HIGH
1.400
LOW
1.350
VOLUME
10.54K
TURNOVER
--
52 WEEK HIGH
3.855
52 WEEK LOW
1.340
MARKET CAP
9.06M
P/E (TTM)
2.304
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of XTLB and other stocks commission-free!

Open a Webull account and fund it to get a free stock

EPS

XTLB News

  • The Daily Biotech Pulse: Biogen Alzheimer's Program Back On Track, Novartis Reports Strong Quarter, Takeda In-Licenses Autoimmune Disorder Drug
  • Benzinga.15h ago
  • BNTX, COTY, INFY, MFGP and SGEN among midday movers
  • Seeking Alpha - Article.1d ago
  • The Daily Biotech Pulse: J&J Settles Ohio Opioid Lawsuit, Teligent Explores Options For Certain Assets, Novartis Reports Cosentyx Data
  • Benzinga.10/02 11:17
  • The Daily Biotech Pulse: ESMO Conference Gets Underway, J&J's Darzalex Snags Another Approval, Kaleido Biosciences CFO To Leave
  • Benzinga.09/27 11:56

More

Industry

Biotechnology & Medical Research
+0.44%
Pharmaceuticals & Medical Research
+0.60%

Hot Stocks

Name
Price
%Change

About XTLB

XTL Biopharmaceuticals Ltd. is a biopharmaceutical company. The Company focuses on the acquisition and development of pharmaceutical drugs for the treatment of medical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action, for the treatment of Systemic Lupus Erythematosus (SLE). hCDR1 is a synthetic peptide that includes approximately 20 amino-acid residues. rHuEPO, a known agent for anemia, is being developed to prolong the survival of patients with advanced multiple myeloma (MM). rHuEPO is used in clinical practice for the treatment of various anemias, including anemia of kidney disease and cancer-related anemia.
More

Webull offers X T L Biopharmaceuticals Ltd (ADR) (XTLB) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.